Revolution Medicines (RVMD) Deferred Taxes (2019 - 2024)
Revolution Medicines' (RVMD) quarterly Deferred Taxes came in at $762000.0 in Q4 2024, up 1672.09% year-on-year from $43000.0 in Q1 2024, and up 1672.09% quarter-over-quarter from $43000.0 in Q4 2023.
Revolution Medicines (RVMD) Deferred Taxes (2019 - 2024) Analysis & Trends
Revolution Medicines' Deferred Taxes history runs 5 years deep, the most recent figure standing at $762000.0 for Q4 2024.
- On a quarterly basis, Deferred Taxes rose 1672.09% year-over-year to $762000.0 in Q4 2024; TTM through Dec 2024 was $928000.0, a 580.83% increase from a year earlier, with the FY2024 full-year figure at $762000.0, down 80.51% from the prior year.
- Deferred Taxes rose to $762000.0 in Q4 2024 per RVMD's latest filing, from $43000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $762000.0 in Q4 2024 and bottomed at -$359000.0 in Q4 2020.
- The 4-year median for Deferred Taxes is $83000.0 (2022), against an average of $217166.7.
- Across the five-year window, Deferred Taxes plunged 107.56% in 2020 and jumped 1672.09% in 2024, its largest moves.
- Year by year, Deferred Taxes stood at -$359000.0 in 2020, then surged by 134.26% to $123000.0 in 2022, then tumbled by 65.04% to $43000.0 in 2023, then soared by 1672.09% to $762000.0 in 2024.
- Per Business Quant, the three latest RVMD Deferred Taxes figures stand at $762000.0 (Q4 2024), $43000.0 (Q4 2023), and $123000.0 (Q4 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 762,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Dec 31, 2022 | 123,000.00 |
| Dec 31, 2020 | -359,000.00 |
| Jun 30, 2020 | 18,000.00 |
| Mar 31, 2020 | 716,000.00 |
| Dec 31, 2019 | 4.75 Mn |
| Sep 30, 2019 | -141,000.00 |
| Jun 30, 2019 | -136,000.00 |
| Mar 31, 2019 | -96,000.00 |